搜索临床试验以:LYR-210
总计5012个结果
-
CHDI Foundation, Inc.Dr. Glenn T. Stebbins (Rush University Medical Center ); Dr. Nancy LaPelle完全的
-
BioMarin Pharmaceutical终止
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
World Medicine ILAC SAN. ve TIC. A.S.Novagenix Bioanalytical Drug R&D Center; Farmagen Ar-Ge Biyot. Ltd. Sti完全的
-
Memorial Sloan Kettering Cancer CenterHookipa Biotech GmbH; Naveris招聘中
-
Bürgerspital SolothurnUniversity Hospital, Basel, Switzerland完全的
-
Jazz Pharmaceuticals完全的
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...主动,不招人
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical Devices完全的
-
University of PittsburghThe Grable Foundation; Department Human Services, Pennsylvania; Fisa Foundation完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.未知肝细胞癌 | 非小细胞肺癌 | 钢筋混凝土
-
Heart and Diabetes Center North-Rhine WestfaliaItamar-Medical, Israel完全的
-
University of Kansas Medical CenterNational Institute of Mental Health (NIMH); Children's Mercy Hospital Kansas City; Kenya Medical... 和其他合作者完全的
-
Conmed Pharmaceutical & Bio-Medical CorporationChang Gung Memorial Hospital; Kaohsiung Medical University; Tri-Service General Hospital; Taichung... 和其他合作者完全的
-
Merck Sharp & Dohme LLC主动,不招人复发或难治性弥漫性大 B 细胞淋巴瘤美国, 中国, 波兰, 以色列, 加拿大, 智利, 捷克语, 爱沙尼亚, 法国, 希腊, 意大利, 大韩民国, 挪威, 西班牙, 瑞典, 泰国, 火鸡
-
Matthew BucknorFocused Ultrasound Foundation; InSightec-TxSonics招聘中
-
Shanghai Jiao Tong University School of Medicine完全的
-
University of EdinburghKidney Cancer UK完全的